Clinical trial
Study to Evaluate the Safety and Efficacy of Adeno-IFN Gamma in Cutaneous B-cell…
NCT00394693 · Transgene, Industry · Completed
Key facts
| NCT number | NCT00394693 |
|---|---|
| Title | Study to Evaluate the Safety and Efficacy of Adeno-IFN Gamma in Cutaneous B-cell Lymphoma |
| Official title | Phase II Clinical Trial of Intra-lesional Administration of TG1042 (Adenovirus-Interferon-gamma) in Patients With Relapsing Primary Cutaneous B-Cell Lymphomas. |
| Lead sponsor | Transgene, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma, B-Cell |
| Intervention type | Genetic |
| Interventions | Adenovirus Interferon gamma |
| Enrollment | 13 |
| Start date | Nov 1, 2006 |
| Primary completion | Jan 1, 2010 |
| Completion | Apr 1, 2010 |
| First posted | Nov 1, 2006 |
| Last update posted | Jul 16, 2014 |
| Countries | France, Switzerland, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: